Despite the distinct involvement of α-synuclein and tau in parkinsonisms, their potential role as biomarkers in distinguishing between PD and PSP patients has been scarcely investigated [13,22,23,24,25,26,27,30]. The gene discussed is MAPT; the disease is Parkinsonism.